ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,019Medicare Part D Prescriptions Filled, Including Refills

Rank: 227 out of 972

$516K Total Retail Price of All Prescriptions

Rank: 302 out of 972

632 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,393 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 579 530 1 1
LOVASTATIN 503 461 2 22
LEVOTHYROXINE SODIUM 477 438 3 3
ATENOLOL 386 382 4 18
SIMVASTATIN 384 380 5 2
HYDROCHLOROTHIAZIDE 358 349 6 10
FUROSEMIDE 339 316 7 7
METFORMIN HCL 337 312 8 8
TRAMADOL HCL 258 251 9 15
OMEPRAZOLE 258 252 9 5
ATORVASTATIN CALCIUM 221 208 11 11
HYDROCODONE-ACETAMINOPHEN 208 184 S3 12 6
AMLODIPINE BESYLATE 195 190 13 4
METOPROLOL TARTRATE 180 178 14 9
FLUOXETINE HCL 157 146 15 60
POTASSIUM CHLORIDE 156 148 16 13
CITALOPRAM HBR 152 147 17 19
ZOLPIDEM TARTRATE 140 138 18 23
DONEPEZIL HCL 140 140 18 26
GLIPIZIDE 123 114 20 59
DICLOFENAC SODIUM 112 88 21 130
ALENDRONATE SODIUM 107 107 22 27
WARFARIN SODIUM 107 104 22 12
TAMSULOSIN HCL 100 98 24 29
DIGOXIN 93 89 25 52
ALLOPURINOL 92 92 26 28
FLUTICASONE PROPIONATE 88 86 27 31
DIOVAN 88 76 27 48
METOPROLOL SUCCINATE 84 84 29 16
KLOR-CON 10 83 83 30 68
CLOPIDOGREL 83 81 30 37
GABAPENTIN 83 71 30 14
OXYBUTYNIN CHLORIDE 80 80 33 97
GLYBURIDE 79 79 R 34 70
AMITRIPTYLINE HCL 77 77 R 35 58
PAROXETINE HCL 76 75 36 64
NAPROXEN 75 74 37 71
CRESTOR 73 73 38 33
TRAZODONE HCL 72 68 39 35
CAPTOPRIL 71 71 40 256
ZETIA 71 71 40 79
PREDNISONE 69 65 42 40
DILTIAZEM 24HR CD 66 66 43 74
CELEBREX 64 64 44 85
PLAVIX 64 60 44 55
CARVEDILOL 61 50 46 21
AZITHROMYCIN 61 58 46 42
PROPRANOLOL HCL 60 57 48 118
ALPRAZOLAM 58 44 49 288
ENALAPRIL MALEATE 54 54 50 50
CYCLOBENZAPRINE HCL 54 47 R 50 53
ADVAIR DISKUS 52 50 52 45
AMIODARONE HCL 51 51 53 165
FENOFIBRATE 51 47 53 66
GEMFIBROZIL 50 50 55 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.